TrialBritish journal of haematology2009

Phase II study of a TLR-9 agonist (1018 ISS) with rituximab in patients with relapsed or refractory follicular lymphoma.

Jonathan W Friedberg et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.